دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Climate change and skin cancer: urgent call for action
doi : 10.1016/S1470-2045(23)00348-0
Volume 24, Issue 8, August 2023, Page 823
Aspartame: it is the risk that matters, not the hazard
Kevin McConway
doi : 10.1016/S1470-2045(23)00342-X
Volume 24, Issue 8, August 2023, Pages 824-825
2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic
Julie S Townsend
doi : 10.1016/S1470-2045(23)00337-6
Volume 24, Issue 8, August 2023, Pages 825-826
Improving functional outcomes for patients with head and neck cancer
Sandra Nuyts
doi : 10.1016/S1470-2045(23)00281-4
Volume 24, Issue 8, August 2023, Pages 827-828
Decentralised, point-of-care CAR-T for multiple myeloma
*Sébastien Anguille, Laurens Krekelbergh
doi : 10.1016/S1470-2045(23)00269-3
Volume 24, Issue 8, August 2023, Pages 828-830
Artificial intelligence for breast cancer screening: breathtaking results and a word of caution
Nereo Segnan, Antonio Ponti
doi : 10.1016/S1470-2045(23)00336-4
Volume 24, Issue 8, August 2023, Pages 830-832
Retraction and republication—Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
doi : 10.1016/S1470-2045(23)00327-3
Volume 24, Issue 8, August 2023, Page 832
Common Sense Oncology: outcomes that matter
Christopher M Booth, Manju Sengar, Aaron Goodman, Brooke Wilson, Ajay Aggarwal, Scott Berry, David Collingridge, Avram Denburg, Elizabeth A Eisenhauer, Ophira Ginsburg, Daniel Goldstein, Sanjeeva Gunasekera, Nazik Hammad, Kazunori Honda, Christopher Jackson, Deme Karikios, Kevin Knopf, Rachel Koven, Bernard L Marini, Deborah Maskens, Fabio Y Moraes, Ghulam Rehman Mohyuddin, Bishesh Sharma Poudyal, C S Pramesh, Felipe Roitberg, Fidel Rubagumya, Sally Schott, Bhawna Sirohi, Enrique Soto-Perez-de-Celis, Richard Sullivan, Ian F Tannock, Dario Trapani, Michelle Tregear, Winette van der Graaf, Verna Vanderpuye, Bishal Gyawali
doi : 10.1016/S1470-2045(23)00319-4
Volume 24, Issue 8, August 2023, Pages 833-835
Establishing a Lancet Oncology Commission on the humanitarian crisis of cancer
Gary Rodin, Mac Skelton, Nirmala Bhoo-Pathy, Omar Dewachi, Madeline Li, Dario Trapani, Elizabeth Smyth, Matthew Banegas, Naveen Salins, Karla Unger-Salda?a, Camilla Zimmermann, Richard Sullivan
doi : 10.1016/S1470-2045(23)00346-7
Volume 24, Issue 8, August 2023, Pages 835-837
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed
Rahul Jena, *Rami Issa, Matthew Perry
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed – Authors' reply
Alexandre R Zlotta, Katherine Lajkosz, Jason A Efstathiou
doi : 10.1016/S1470-2045(23)00322-4
Volume 24, Issue 8, August 2023, Pages e325-e326
Retraction and republication—TRICOTEL: defining symptomatic brain metastases in clinical trials
*Reinhard Dummer, Hussein Tawbi
doi : 10.1016/S1470-2045(23)00292-9
Volume 24, Issue 8, August 2023, Page e327
Correction to Lancet Oncol 2023; 24: 611–23
doi : 10.1016/S1470-2045(23)00351-0
Volume 24, Issue 8, August 2023, Page e328
Correction to Lancet Oncol 2023; 24: 868–80
doi : 10.1016/S1470-2045(23)00350-9
Volume 24, Issue 8, August 2023, Page e328
Correction to Lancet Oncol 2023; published online July 13. https://doi.org/10.1016/S1470-2045(23)00342-X
doi : 10.1016/S1470-2045(23)00345-5
Volume 24, Issue 8, August 2023, Page e328
Middle-age lung screening for everyone who has smoked
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00325-X
Volume 24, Issue 8, August 2023, Page 838
Biomarker tests for targeted oncology therapies pose tricky regulatory challenges
Kathryn Senior
doi : 10.1016/S1470-2045(23)00326-1
Volume 24, Issue 8, August 2023, Page 839
NCRI stuns cancer trial researchers with closure announcement
Emma Wilkinson
doi : 10.1016/S1470-2045(23)00328-5
Volume 24, Issue 8, August 2023, Page 840
Improving cancer outcomes in low-income areas in the USA
Munyaradzi Makoni
doi : 10.1016/S1470-2045(23)00331-5
Volume 24, Issue 8, August 2023, Page 841
NHS England ends treatment break rule in bowel cancer
Kathryn Senior
doi : 10.1016/S1470-2045(23)00330-3
Volume 24, Issue 8, August 2023, Page 842
US Supreme Court ruling on affirmative action impacts oncology
Manjulika Das
doi : 10.1016/S1470-2045(23)00332-7
Volume 24, Issue 8, August 2023, Page 843
Projected rise in cancer cases in France
Barbara Casassus
doi : 10.1016/S1470-2045(23)00333-9
Volume 24, Issue 8, August 2023, Page 844
Egypt launches 100 Healthy Days health-care campaign
Manjulika Das
doi : 10.1016/S1470-2045(23)00338-8
Volume 24, Issue 8, August 2023, Page 845
UK–BioNTech partnership for mRNA cancer vaccines
Emma Wilkinson
doi : 10.1016/S1470-2045(23)00339-X
Volume 24, Issue 8, August 2023, Page 846
South Korea backs Japanese plan to release Fukushima waste water
Manjulika Das
doi : 10.1016/S1470-2045(23)00340-6
Volume 24, Issue 8, August 2023, Page 847
Carcinogenicity of aspartame, methyleugenol, and isoeugenol
Elio Riboli, Frederick A Beland, Dirk W Lachenmeier, M Matilde Marques, David H Phillips, Eva Schernhammer, Abdul Afghan, Ricardo Assunç?o, Giovanna Caderni, J Christopher Corton, Gisela de Arag?o Umbuzeiro, Daphne de Jong, Melanie Deschasaux-Tanguy, Allison Hodge, Junko Ishihara, Dan D Levy, Daniele Mandrioli, Marjorie L McCullough, Sarah A McNaughton, Takeshi Morita, Anne P Nugent, Kumiko Ogawa, Arun R Pandiri, Consolato M Sergi, Mathilde Touvier, Luoping Zhang, Lamia Benbrahim-Tallaa, Shirisha Chittiboyina, Danila Cuomo, Nathan L DeBono, Charlotte Debras, Aline de Conti, Fatiha El Ghissassi, Emma Fontvieille, Rhea Harewood, John Kaldor, Heidi Mattock, Elisa Pasqual, Gabrielle Rigutto, Hannah Simba, Eero Suonio, Susana Viegas, Roland Wedekind, Mary K Schubauer-Berigan, Federica Madia
doi : 10.1016/S1470-2045(23)00341-8
Volume 24, Issue 8, August 2023, Pages 848-850
Growing liver cancer death rates in the UK call for healthier lifestyle choices
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00352-2
Volume 24, Issue 8, August 2023, Page e329
NHS embraces AI-assisted radiotherapy technology
Kathryn Senior
doi : 10.1016/S1470-2045(23)00353-4
Volume 24, Issue 8, August 2023, Page e330
ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma
Riccardo Nocini, Luca Tondulli, Consuelo D’Ambrosio, Claudio Luchini, Andrew V Biankin, *Raffaella Casolino, *Aldo Scarpa, ICGC-ARGO†, Michele Milella‡, Rita T Lawlor‡
doi : 10.1016/S1470-2045(23)00241-3
Volume 24, Issue 8, August 2023, Pages 851-853
ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma
Riccardo Nocini, Luca Tondulli, Consuelo D’Ambrosio, Claudio Luchini, Andrew V Biankin, *Raffaella Casolino, *Aldo Scarpa, ICGC-ARGO†, Michele Milella‡, Rita T Lawlor‡
doi : 10.1016/S1470-2045(23)00241-3
Volume 24, Issue 8, August 2023, Pages 851-853
The post-truth anti-science era: what and who can we trust?
Jules Morgan
doi : 10.1016/S1470-2045(23)00349-2
Volume 24, Issue 8, August 2023, Pages 853-854
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment
Xuesong Han, Nuo Nova Yang, Leticia Nogueira, Changchuan Jiang, Nikita Sandeep Wagle, Jingxuan Zhao, Kewei Sylvia Shi, Qinjin Fan, Elizabeth Schafer, K Robin Yabroff, Ahmedin Jemal
doi : 10.1016/S1470-2045(23)00293-0
Volume 24, Issue 8, August 2023, Pages 855-867
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial
Christopher Nutting, Laura Finneran, Justin Roe, Mark A Sydenham, Matthew Beasley, Shree Bhide, Cheng Boon, Audrey Cook, Emma De Winton, Marie Emson, Bernadette Foran, Robert Frogley, Imran Petkar, Laura Pettit, Keith Rooney, Tom Roques, Devraj Srinivasan, Justine Tyler, Emma Hall, on behalf of the DARS Trialist Group
doi : 10.1016/S1470-2045(23)00265-6
Volume 24, Issue 8, August 2023, Pages 868-880
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Laurence Albiges*, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A Climent, David Pook, Piotr Tomczak, Philippe Barthelemy, Jae Lyun Lee, Viktor Stus, Thomas Ferguson, Pawel Wiechno, Erhan Gokmen, Louis Lacombe, Craig Gedye, Rodolfo F Perini, Manish Sharma, Xiang Peng, Chung-Han Lee*
doi : 10.1016/S1470-2045(23)00276-0
Volume 24, Issue 8, August 2023, Pages 881-891
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
Jean-Yves Blay, Sylvie Chevret, Axel Le Cesne, Mehdi Brahmi, Nicolas Penel, Sophie Cousin, Francois Bertucci, Emmanuelle Bompas, Thomas Ryckewaert, Pauline Soibinet, Pascaline Boudou-Rouquette, Esma Saada Bouzid, Patrick Soulie, Thibaud Valentin, Jean-Pierre Lotz, Diego Tosi, Zoé Neviere, Mathilde Cancel, Isabelle Ray-Coquard, Laetitia Gambotti, Frédéric Legrand, Assia Lamrani-Ghaouti, Clotilde Simon, Caroline Even, Christophe Massard
doi : 10.1016/S1470-2045(23)00282-6
Volume 24, Issue 8, August 2023, Pages 892-902
Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030
Arthur Accioly Rosa, Cec?lia Félix Penido Mendes de Sousa, Leonardo Cunha Furbino Pimentel, Homero Lavieri Martins, Fabio Ynoe Moraes, Gustavo Nader Marta, Marcus Sim?es Castilho
doi : 10.1016/S1470-2045(23)00284-X
Volume 24, Issue 8, August 2023, Pages 903-912
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
Aina Oliver-Caldés, Ver?nica Gonz?lez-Calle, Valent?n Caba?as, Marta Espa?ol-Rego, Paula Rodr?guez-Otero, Juan Luis Reguera, Luc?a L?pez-Corral, Beatriz Martin-Antonio, Aintzane Zabaleta, Susana Inogés, Sara Varea, Laura Rosi?ol, Ascensi?n L?pez-D?az de Cerio, Natalia Tovar, Raquel Jiménez, Miriam L?pez-Parra, Luis Gerardo Rodr?guez-Lobato, Andrés S?nchez-Salinas, Eulà lia Olesti, Maria Calvo-Orteu, Julio Delgado, José Antonio Pérez-Sim?n, Bruno Paiva, Felipe Pr?sper, Joaqu?n S?ez-Pe?ataro, Manel Juan, José M Moraleda, Mar?a-Victoria Mateos, Mariona Pascal, Alvaro Urbano-Ispizua, Carlos Fern?ndez de Larrea
doi : 10.1016/S1470-2045(23)00222-X
Volume 24, Issue 8, August 2023, Pages 913-924
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Shubham Pant, Martin Schuler, Gopa Iyer, Olaf Witt, Toshihiko Doi, Shukui Qin, Josep Tabernero, David A Reardon, Christophe Massard, Anna Minchom, Iwona Lugowska, Omar Carranza, Dirk Arnold, Martin Gutierrez, Helen Winter, Kim Stuyckens, Lauren Crow, Saltanat Najmi, Constance Hammond, Shibu Thomas, Ademi Santiago-Walker, Spyros Triantos, Hussein Sweiti, Yohann Loriot, on behalf of the RAGNAR Investigators
doi : 10.1016/S1470-2045(23)00275-9
Volume 24, Issue 8, August 2023, Pages 925-935
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
Kristina L?ng, Viktoria Josefsson, Anna-Maria Larsson, Stefan Larsson, Charlotte H?gberg, Hanna Sartor, Solveig Hofvind, Ingvar Andersson, Aldana Rosso
doi : 10.1016/S1470-2045(23)00298-X
Volume 24, Issue 8, August 2023, Pages 936-944
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, Nandita M deSouza, David Krug, Laurence Collette, Wolfgang Kunz, Yazid Belkacemi, Maria Grazia Bau, Caroline Caramella, Lioe-Fee De Geus-Oei, Alex De Caluwé, Christophe Deroose, Olivier Gheysens, Ken Herrmann, Isabelle Kindts, Michalis Kontos, Sherko Kümmel, Barbro Linderholm, Egesta Lopci, Icro Meattini, Ann Smeets, Orit Kaidar-Person, Philip Poortmans, Pelagia Tsoutsou, Nawale Hajjaji, Nicola Russell, El?bieta Senkus, Jean-Noël Talbot, Lale Umutlu, Vincent Vandecaveye, Joost J C Verhoeff, Willemien Menke-van der Houven van Oordt, Helle D Zacho, Fatima Cardoso, Laure Fournier, Frederieke Van Duijnhoven, Frédéric E Lecouvet
doi : 10.1016/S1470-2045(23)00286-3
Volume 24, Issue 8, August 2023, Pages e331-e343
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
Michelle M Kim, Minesh P Mehta, DeeDee K Smart, Patricia S Steeg, Julie A Hong, Michael G Espey, Pataje G Prasanna, Laura Crandon, Christine Hodgdon, Niki Kozak, Terri S Armstrong, Aki Morikawa, Nicole Willmarth, Kirk Tanner, Adrienne Boire, Melanie Hayden Gephart, Kim A Margolin, Jona Hattangadi-Gluth, Hussein Tawbi, Daniel M Trifiletti, Caroline Chung, Upal Basu-Roy, Robyn Burns, Isabella C Glitza Oliva, Ayal A Aizer, Carey K Anders, Joanne Davis, Manmeet S Ahluwalia, Veronica Chiang, Jing Li, Rupesh Kotecha, Silvia C Formenti, Benjamin M Ellingson, Vinai Gondi, Paul W Sperduto, Jill S Barnholtz-Sloan, Jordi Rodon, Eudocia Q Lee, Mustafa Khasraw, Debra Nana Yeboa, Priscilla K Brastianos, Evanthia Galanis, C Norman Coleman, Mansoor M Ahmed
doi : 10.1016/S1470-2045(23)00297-8
Volume 24, Issue 8, August 2023, Pages e344-e354
Metastatic seminoma masquerading as sarcoidosis
Kevin E Shopsowitz, Xiu Qing Wang, Maryam Soleimani, Monika Hudoba, Luke Y C Chen, Eric McGinnis
doi : 10.1016/S1470-2045(23)00287-5
Volume 24, Issue 8, August 2023, Page e355
